Skip to main content

Merck & Co., Inc. Keytruda revenue

  • MRK · NYSE
  • Pharmaceuticals
  • S&P 500
$147.76+0.55%Close 13 Nov 2026 · Market value $361.6B

Keytruda revenue at Merck & Co., Inc. came to $7.8B for the quarter to 30 Sep 2026, down 4.6% from a year earlier.

As Merck & Co., Inc. reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 4 Nov 2026.

By quarter

$6.6BDec 2023$6.9BMar 2024$7.3BJun 2024$7.4BSep 2024$7.8BDec 2024$7.2BMar 2025$8.0BJun 2025$8.1BSep 2025$8.3BDec 2025$7.9BMar 2026$7.9BJun 2026$7.8BSep 2026
Merck & Co., Inc. Keytruda revenue, every reported period
Period endingKeytruda revenueChange on a yearFiled
30 Sep 2026$7.8Bdown 4.6%4 Nov 2026
30 Jun 2026$7.9Bdown 0.7%7 Aug 2026
31 Mar 2026$7.9Bup 9.7%4 May 2026
31 Dec 2025$8.3Bup 6.4%24 Feb 2026
30 Sep 2025$8.1Bup 9.6%5 Nov 2025
30 Jun 2025$8.0Bup 9.4%5 Aug 2025
31 Mar 2025$7.2Bup 3.7%2 May 2025
31 Dec 2024$7.8Bup 18.6%25 Feb 2025
30 Sep 2024$7.4Bup 17.2%6 Nov 2024
30 Jun 2024$7.3Bup 15.9%5 Aug 2024
31 Mar 2024$6.9Bup 19.9%3 May 2024
31 Dec 2023$6.6Bup 21.2%26 Feb 2024
30 Sep 2023$6.3Bup 16.8%3 Nov 2023
30 Jun 2023$6.3Bup 19.4%7 Aug 2023
31 Mar 2023$5.8Bup 20.5%5 May 2023
31 Dec 2022$5.5Bup 19.1%24 Feb 2023
30 Sep 2022$5.4Bup 19.7%3 Nov 2022
30 Jun 2022$5.3Bup 25.8%5 Aug 2022
31 Mar 2022$4.8Bup 23.3%5 May 2022
31 Dec 2021$4.6Bup 14.6%25 Feb 2022
30 Sep 2021$4.5Bup 22.0%5 Nov 2021
30 Jun 2021$4.2Bup 23.3%9 Aug 2021
31 Mar 2021$3.9Bup 18.7%5 May 2021
31 Dec 2020$4.0Bup 28.4%25 Feb 2021
30 Sep 2020$3.7Bup 21.0%5 Nov 2020
30 Jun 2020$3.4Bup 28.6%5 Aug 2020
31 Mar 2020$3.3Bup 44.7%6 May 2020
31 Dec 2019$3.1Bup 44.6%26 Feb 2020
30 Sep 2019$3.1Bup 62.5%5 Nov 2019
30 Jun 2019$2.6Bup 58.0%6 Aug 2019
31 Mar 2019$2.3Bup 55.0%8 May 2019
31 Dec 2018$2.2B—27 Feb 2019
30 Sep 2018$1.9Bup 80.4%6 Nov 2018
30 Jun 2018$1.7Bup 89.2%7 Aug 2018
31 Mar 2018$1.5B—8 May 2018
30 Sep 2017$1.0B—7 Nov 2017
30 Jun 2017$881.0M—8 Aug 2017

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Merck & Co., Inc.: Gardasil/Gardasil 9 revenue · Livestock revenue · Keytruda Qlex revenue · ProQuad/M-M-R II/Varivax revenue · Winrevair revenue · Companion Animal revenue · Lynparza alliance revenue · Prevymis revenue · Welireg revenue · Lenvima alliance revenue · Capvaxive revenue · RotaTeq revenue · Vaxneuvance revenue · Janumet revenue · Januvia revenue · Ohtuvayre revenue · Reblozyl alliance revenue · Bridion revenue · Adempas/Verquvo alliance revenue · Zerbaxa revenue · Adempas revenue · Delstrigo revenue · Isentress/Isentress HD revenue · Belsomra revenue · financial statements

Every KPI and segment of MRK, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.